Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lucid Diagnostics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.398 Good morning, and welcome to the Lucid Diagnostics third quarter 2025 business 00:00:05.398 -- 00:00:09.583 update conference call. Please note, this event is being recorded. 00:00:09.583 -- 00:00:15.150 I would now like to turn the conference over to Matt Riley, Director, Investor Relations. 00:00:15.150 -- 00:00:17.911 Please go ahead, sir. 00:00:18.053 -- 00:00:20.396 Thank you, operator, and good morning, everyone. 00:00:20.396 -- 00:00:23.320 Thank you for participating in today's business update call. 00:00:23.320 -- 00:00:28.046 Joining me today on the call are Dr. Leishan Aklag, Chairman and CEO of Lucid Diagnostics, 00:00:28.046 -- 00:00:32.549 along with Dennis McGrath, CFO. The press release announcing our business update and 00:00:32.549 -- 00:00:34.932 financial results is available on Lucid's website. 00:00:34.932 -- 00:00:38.777 Please take a moment to read the disclaimers about forward-looking statements in the 00:00:38.777 -- 00:00:43.342 press release. The business update, press release, and the conference call all include 00:00:43.342 -- 00:00:46.566 forward-looking statements, and these forward-looking statements are subject to known 00:00:46.566 -- 00:00:51.291 and unknown risks and uncertainties that may cause actual results to differ materially 00:00:51.291 -- 00:00:56.577 from statements made. Factors that could cause actual results to differ are described 00:00:56.577 -- 00:00:59.701 in the disclaimer and in our filings with the SEC. 00:00:59.701 -- 00:01:04.087 For a list and description of these and other important risks and uncertainties that 00:01:04.087 -- 00:01:09.094 may affect future operations, see Part 1, Item 1A, entitled Risk 00:01:09.094 -- 00:01:14.201 Factors in Lucid's most recent annual rep...